High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
4.35B
+7%
0.593
+2.16%
3.83B
+5.41%
0.427
+1.57%
4.35B
+4.56%
0.530
+8.25%
Estimates Revision
The market is revising Upward the revenue expectations for Keurig Dr Pepper Inc. (KDP) for FY2025, with the revenue forecasts being adjusted by 0.9% over the past three months. During the same period, the stock price has changed by -20.87%.
Revenue Estimates for FY2025
Revise Upward
+0.9%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-0.1%
In Past 3 Month
Stock Price
Go Down
-20.87%
In Past 3 Month
15 Analyst Rating
Wall Street analysts forecast KDP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KDP is 33.60 USD with a low forecast of 24.00 USD and a high forecast of 42.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
5 Hold
1 Sell
Moderate Buy
Current: 27.420
Low
24.00
Averages
33.60
High
42.00
Current: 27.420
Low
24.00
Averages
33.60
High
42.00
Jefferies
Buy
downgrade
$41 -> $39
2025-10-29
Reason
Jefferies
Price Target
$41 -> $39
2025-10-29
downgrade
Buy
Reason
Jefferies lowered the firm's price target on Keurig Dr Pepper to $39 from $41 and keeps a Buy rating on the shares after "a largely successful" investor day getting investors to move past "errors of the original JDEP deal." The nature of the deal is tricky, as the new $7B strategic investment swaps out traditional debt with a payout structure that involves a joint venture and preferred equity, but the firm thinks the strategic rationale and accretion targets remain "sensible" and unchanged, the analyst tells investors.
Wells Fargo
Overweight
maintain
$33 -> $35
2025-10-28
Reason
Wells Fargo
Price Target
$33 -> $35
2025-10-28
maintain
Overweight
Reason
Wells Fargo raised the firm's price target on Keurig Dr Pepper to $35 from $33 and keeps an Overweight rating on the shares. The firm believes debates will remain loud as it thinks the name has much to prove. With that said, Wells argues that Keurig Dr Pepper may intrigue just a touch more after solid core results, and a fresh financing that substantially reduces debt, a combination it sees bringing forward the company's investment case several years.
Barclays
Lauren Lieberman
Equal Weight
maintain
$26 -> $30
2025-10-28
Reason
Barclays
Lauren Lieberman
Price Target
$26 -> $30
2025-10-28
maintain
Equal Weight
Reason
Barclays analyst Lauren Lieberman raised the firm's price target on Keurig Dr Pepper to $30 from $26 and keeps an Equal Weight rating on the shares following the investor day. The company's updates around financing and post-separation capital structure proved more constructive than expected, the analyst tells investors in a research note.
JPMorgan
Andrea Teixeira
Overweight
downgrade
$39 -> $36
2025-10-20
Reason
JPMorgan
Andrea Teixeira
Price Target
$39 -> $36
2025-10-20
downgrade
Overweight
Reason
JPMorgan analyst Andrea Teixeira lowered the firm's price target on Keurig Dr Pepper to $36 from $39 and keeps an Overweight rating on the shares ahead of the Q3 report on October 27. The firm trimmed estimates to reflect Keurig's international mix. It believes the stock could be range-bound for the time being.
TD Cowen
Robert Moskow
Hold
downgrade
$36 -> $28
2025-10-01
Reason
TD Cowen
Robert Moskow
Price Target
$36 -> $28
2025-10-01
downgrade
Hold
Reason
TD Cowen analyst Robert Moskow lowered the firm's price target on Keurig Dr Pepper to $28 from $36 and keeps a Hold rating on the shares. The firm maintained its Q3 and 2025 EPS estimates and expect te company will reiterate guidance when they report.
Barclays
Overweight -> Equal Weight
downgrade
$39 -> $26
2025-09-24
Reason
Barclays
Price Target
$39 -> $26
2025-09-24
downgrade
Overweight -> Equal Weight
Reason
Barclays downgraded Keurig Dr Pepper to Equal Weight from Overweight with a price target of $26, down from $39. While the company's asset reshuffling could be the right move longer term, the transactions "present elevated noise and uncertainty over the next 12 months," the analyst tells investors in a research note. Barclays is challenged to believe new information at Keurig's investor event in October will serve as a positive catalyst "as there will be plenty to bear out over time." It cites heightened complexity in the Keurig narrative near term for the downgrade.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Keurig Dr Pepper Inc (KDP.O) is 12.67, compared to its 5-year average forward P/E of 18.73. For a more detailed relative valuation and DCF analysis to assess Keurig Dr Pepper Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Strongly Undervalued
5Y Average PE
18.73
Current PE
12.67
Overvalued PE
21.40
Undervalued PE
16.06
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
14.26
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
15.59
Undervalued EV/EBITDA
12.93
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Strongly Overvalued
5Y Average PS
3.54
Current PS
26.96
Overvalued PS
6.00
Undervalued PS
1.08
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 842.59% over the last quarter.
Sold
Bought
Congress Trading
Congress areSelling! The selling amount has increased200%over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
KDP News & Events
Events Timeline
(ET)
2025-11-17
12:24:37
Video: Meet the Wall Street-Approved Winners from Food Tariff Relief
2025-11-16 (ET)
2025-11-16
17:38:59
Piper identifies three companies poised to gain from revised Trump tariffs.
2025-10-27 (ET)
2025-10-27
09:55:01
Significant Early Gainers in Liquid Options on October 27th
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/411118eeb43cc7fa79ab6a58175bd4615c6d13a4b5049378d3312af2294d4abc.jpg)
Preview
4.5
11-18NASDAQ.COMMost Active Stocks After Hours on November 17, 2025: NVDA, CSCO, F, PFE, RUN, INTC, KDP, HBAN, HPE, JNJ, BAC, KO
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/0ee101e0c15a376dc84979b29bdaf4b98f3ca76070a9a10564492b6e787f072f.jpg)
Preview
8.0
11-17NASDAQ.COMFebruary 2026 Options for Keurig Dr Pepper (KDP) Now Accessible
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/3d0eb779b5bc1d670c709d6337844df2d1f26b7405f123c3a8134e3d933f2bbe.png)
Preview
1.0
11-17NewsfilterCasey's and Dr Pepper® Launch $100,000 Tuition Giveaway for Fansville
Sign Up For More News
People Also Watch
FAQ
What is Keurig Dr Pepper Inc (KDP) stock price today?
What is Keurig Dr Pepper Inc (KDP)'s business?
What is the price predicton of KDP Stock?
What is Keurig Dr Pepper Inc (KDP)'s revenue for the last quarter?
What is Keurig Dr Pepper Inc (KDP)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Keurig Dr Pepper Inc (KDP)'s fundamentals?
How many employees does Keurig Dr Pepper Inc (KDP). have?